Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Paraganglioma, Extra-Adrenal, Pheochromocytoma, Prostatic Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary, Breast Neoplasms, Male, Small Cell Lung Carcinoma

NCT01196559 2015-02-18

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

Phase 2 Completed

44 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00002949 2013-09-05

Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis

Phase 1 Completed

33 enrolled

GenitourinaryGynecologic

Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT00002813 2013-05-27

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer

Phase 2 Completed

62 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT00001944 2008-03-04

Vinorelbine and XR9576 to Treat Cancer

Phase 1 Completed

30 enrolled

BreastGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms

Clinical Trials

TroFuse-020

innovaTV 301

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers

SMMART Adaptive Clinical Treatment (ACT) Trial

Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer

Vinorelbine and XR9576 to Treat Cancer